Travere Therapeutics, Inc. (TVTX) SEC filings
TVTX SEC filings moved a median of +0.28% by the close. TVTX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the TVTX overview →
63 measured TVTX SEC filing events.
Where these TVTX SEC filings landedvs 63 measured TVTX SEC filing reactions
| Middle 50% of TVTX SEC filing reactions | -2.60% to +2.90% |
|---|---|
| Median reaction (to close) | +0.28% |
| Measured reactions | 63 |
Point-in-time · zero look-ahead
Half of the 63 TVTX SEC filing events with a measured close landed between -2.60% and +2.90%; 59% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Travere Therapeutics, For: Sep 21 | SEC filing · Form 8-K | +1.26% | -0.15% | |
| Form 10-Q Travere Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +2.73% | +1.23% | |
| Form 8-K Travere Therapeutics, For: Aug 04 | SEC filing · Form 8-K | +2.73% | +1.23% | |
| Form 8-K Travere Therapeutics, For: Jul 06 | SEC filing · Form 8-K | -1.91% | -2.43% | |
| Form S-8 Travere Therapeutics, | SEC filing · Form S-8 | +0.06% | +0.11% | |
| Form 8-K Travere Therapeutics, For: Jun 12 | SEC filing · Form 8-K | +0.80% | +2.04% | |
| Form 8-K Travere Therapeutics, For: Jun 01 | SEC filing · Form 8-K | +0.27% | -2.76% | |
| Form 8-K Travere Therapeutics, For: May 19 | SEC filing · Form 8-K | +0.83% | +0.09% | |
| Form 8-K Travere Therapeutics, For: May 06 | SEC filing · Form 8-K | -0.43% | -0.65% | |
| Form 305B2 Travere Therapeutics, | SEC filing · Form 305B2 | -0.82% | -1.89% | |
| Form 10-Q Travere Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.86% | -3.97% | |
| Form 8-K Travere Therapeutics, For: May 04 | SEC filing · Form 8-K | -1.86% | -3.97% | |
| Form 8-K Travere Therapeutics, For: Apr 13 | SEC filing · Form 8-K | +1.70% | +2.58% | |
| Form ARS Travere Therapeutics, For: Dec 31 | SEC filing · Form ARS | -1.59% | +0.76% | |
| Form DEF 14A Travere Therapeutics, For: May 19 | SEC filing · Form DEF | -1.59% | +0.76% | |
| Form DEFA14A Travere Therapeutics, | SEC filing · Form DEFA14A | -1.59% | +0.76% | |
| Form 10-K Travere Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -4.04% | +3.09% | |
| Form 8-K Travere Therapeutics, For: Feb 19 | SEC filing · Form 8-K | -4.04% | +3.09% | |
| Form 8-K Travere Therapeutics, For: Jan 13 | SEC filing · Form 8-K | -4.63% | -0.41% | |
| Form 8-K Travere Therapeutics, For: Jan 12 | SEC filing · Form 8-K | +5.17% | +26.57% | |
| Form 10-Q Travere Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -1.68% | +2.96% | |
| Form 8-K Travere Therapeutics, For: Oct 30 | SEC filing · Form 8-K | -1.68% | +2.96% | |
| Form 8-K Travere Therapeutics, For: Sep 10 | SEC filing · Form 8-K | +6.25% | +8.07% | |
| Form 10-Q Travere Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -8.97% | -2.87% | |
| Form 8-K Travere Therapeutics, For: Aug 06 | SEC filing · Form 8-K | -8.97% | -2.87% | |
| Form S-8 Travere Therapeutics, | SEC filing · Form S-8 | -0.21% | +2.49% | |
| Form 8-K Travere Therapeutics, For: May 15 | SEC filing · Form 8-K | +0.85% | +2.84% | |
| Form 8-K Travere Therapeutics, For: May 15 | SEC filing · Form 8-K | -2.67% | -6.72% | |
| Form 10-Q Travere Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -3.34% | +0.28% | |
| Form 8-K Travere Therapeutics, For: May 01 | SEC filing · Form 8-K | -3.34% | +0.28% | |
| Form 8-K/A Travere Therapeutics, For: May 01 | SEC filing · Form 8-K | -3.34% | +0.28% | |
| Form 8-K Travere Therapeutics, For: Apr 29 | SEC filing · Form 8-K | +1.17% | +5.63% | |
| Form ARS Travere Therapeutics, For: Dec 31 | SEC filing · Form ARS | +2.33% | +4.49% | |
| Form DEF 14A Travere Therapeutics, For: May 15 | SEC filing · Form DEF | +2.33% | +4.49% | |
| Form DEFA14A Travere Therapeutics, | SEC filing · Form DEFA14A | +2.33% | +4.49% | |
| Form 8-K Travere Therapeutics, For: Mar 17 | SEC filing · Form 8-K | -1.36% | -3.78% | |
| Form 10-K Travere Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.54% | +2.23% | |
| Form 8-K Travere Therapeutics, For: Feb 20 | SEC filing · Form 8-K | -0.54% | +2.23% | |
| Form 8-K Travere Therapeutics, For: Feb 11 | SEC filing · Form 8-K | +1.89% | -1.21% | |
| Form 8-K Travere Therapeutics, For: Jan 13 | SEC filing · Form 8-K | -0.14% | +3.45% | |
| Form 8-K Travere Therapeutics, For: Nov 07 | SEC filing · Form 8-K | +1.05% | -4.56% | |
| Form 10-Q Travere Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +1.73% | +4.17% | |
| Form 8-K Travere Therapeutics, For: Oct 31 | SEC filing · Form 8-K | +1.73% | +4.17% | |
| Form 8-K Travere Therapeutics, For: Sep 26 | SEC filing · Form 8-K | +3.03% | -1.27% | |
| Form 8-K Travere Therapeutics, For: Sep 05 | SEC filing · Form 8-K | +1.67% | +1.67% | |
| Form 10-Q Travere Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -2.50% | -10.18% | |
| Form 8-K Travere Therapeutics, For: Aug 01 | SEC filing · Form 8-K | -2.50% | -10.18% | |
| Form S-3ASR Travere Therapeutics, | SEC filing · Form S-3ASR | -2.50% | -10.18% | |
| Form S-8 Travere Therapeutics, | SEC filing · Form S-8 | -0.35% | +3.09% | |
| Form 8-K Travere Therapeutics, For: May 08 | SEC filing · Form 8-K | +2.32% | +3.71% | |
| Form 10-Q Travere Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -3.92% | -8.78% | |
| Form 8-K Travere Therapeutics, For: May 06 | SEC filing · Form 8-K | -3.92% | -8.78% | |
| Form 8-K Travere Therapeutics, For: Apr 24 | SEC filing · Form 8-K | -2.51% | +0.19% | |
| Form ARS Travere Therapeutics, For: Dec 31 | SEC filing · Form ARS | -1.42% | -0.39% | |
| Form DEF 14A Travere Therapeutics, For: May 08 | SEC filing · Form DEF | -1.42% | -0.39% | |
| Form DEFA14A Travere Therapeutics, | SEC filing · Form DEFA14A | -1.42% | -0.39% | |
| Form 8-K Travere Therapeutics, For: Feb 23 | SEC filing · Form 8-K | +2.61% | +2.17% | |
| Form 10-K Travere Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.98% | +1.84% | |
| Form 8-K Travere Therapeutics, For: Feb 15 | SEC filing · Form 8-K | -3.52% | -6.82% | |
| Form 8-K Travere Therapeutics, For: Jan 08 | SEC filing · Form 8-K | +3.10% | +16.91% | |
| Form 8-K Travere Therapeutics, For: Nov 30 | SEC filing · Form 8-K | +1.78% | +1.09% | |
| Form 10-Q Travere Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -4.56% | -12.45% | |
| Form 8-K Travere Therapeutics, For: Nov 07 | SEC filing · Form 8-K | -4.56% | -12.45% |
Keep exploring
More TVTX: earnings → · analyst actions → · TVTX overview →